United Therapeutics stockUTHR
United Therapeutics trades at $565.72, 7.9% below its 52-week high (Nov 4, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +16.1% year to date, +26.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 24, 2027.
- Earnings WhispersUnited Therapeutics Misses On EPS As Thymmune Charge Obscures Record Revenue And A Tyvaso Reacceleration
- Fiscal.AiUnited Therapeutics Announces Acquisition of Pfizer Royalty Interest in Ralinepag
- Fiscal.AiBTIG Raises Price Target on United Therapeutics
Ratings, candles, signals and the screener for UTHR — after you log in
Open the terminalFrequently asked questions about United Therapeutics
What is the United Therapeutics stock price?
At the close on Nov 5, 2026: $565.72 (−7.03% on the day). 52-week high: $614.23 on Nov 4, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does United Therapeutics report earnings?
The next quarterly report is on Feb 24, 2027. Last quarter, earnings per share changed −20% year over year, revenue +4%.
Does United Therapeutics pay dividends?
No, United Therapeutics does not pay dividends.
Where does United Therapeutics trade and how to buy it?
Ticker UTHR, exchange Nasdaq, listed since 1999. You can buy it through a broker with access to US exchanges.
Should I buy United Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for UTHR are in the terminal after you log in.